Zeke Capital Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $4.56M | Sell |
50,236
-9,374
| -16% | -$850K | 0.3% | 41 |
|
|
2022
Q3 | $4.53M | Sell |
59,610
-28
| -0% | -$2.13K | 0.33% | 41 |
|
|
2022
Q2 | $5.04M | Buy |
59,638
+5,868
| +11% | +$496K | 0.34% | 39 |
|
|
2022
Q1 | $4.72M | Buy |
53,770
+5,641
| +12% | +$495K | 0.24% | 48 |
|
|
2021
Q4 | $4.21M | Buy |
48,129
+4,752
| +11% | +$416K | 0.25% | 40 |
|
|
2021
Q3 | $3.55M | Sell |
43,377
-658
| -1% | -$53.8K | 0.2% | 47 |
|
|
2021
Q2 | $4.02M | Buy |
44,035
+472
| +1% | +$43.1K | 0.25% | 50 |
|
|
2021
Q1 | $3.72M | Hold |
43,563
| – | – | 0.26% | 50 |
|
|
2020
Q4 | $4.11M | Buy |
43,563
+28,735
| +194% | +$2.71M | 0.34% | 40 |
|
|
2020
Q3 | $1.29M | Sell |
14,828
-155
| -1% | -$13.5K | 0.15% | 50 |
|
|
2020
Q2 | $1.31M | Sell |
14,983
-1,369
| -8% | -$120K | 0.25% | 45 |
|
|
2020
Q1 | $1.35M | Sell |
16,352
-33,109
| -67% | -$2.73M | 0.38% | 34 |
|
|
2019
Q4 | $4.68M | Buy |
49,461
+473
| +1% | +$44.8K | 0.39% | 48 |
|
|
2019
Q3 | $4.26M | Buy |
48,988
+391
| +0.8% | +$34K | 0.38% | 55 |
|
|
2019
Q2 | $4.44M | Sell |
48,597
-5,019
| -9% | -$458K | 0.42% | 58 |
|
|
2019
Q1 | $4.62M | Buy |
53,616
+1,024
| +2% | +$88.2K | 0.43% | 48 |
|
|
2018
Q4 | $4.04M | Sell |
52,592
-3,527
| -6% | -$271K | 0.39% | 51 |
|
|
2018
Q3 | $4.33M | Buy |
56,119
+1,572
| +3% | +$121K | 0.35% | 52 |
|
|
2018
Q2 | $3.69M | Buy |
54,547
+49,583
| +999% | +$3.36M | 0.34% | 55 |
|
|
2018
Q1 | $360K | Sell |
4,964
-186
| -4% | -$13.5K | 0.03% | 405 |
|
|
2017
Q4 | $387K | Buy |
5,150
+2,167
| +73% | +$163K | 0.04% | 339 |
|
|
2017
Q3 | $229K | Hold |
2,983
| – | – | 0.03% | 387 |
|
|
2017
Q2 | $223K | Sell |
2,983
-670
| -18% | -$50.1K | 0.04% | 255 |
|
|
2017
Q1 | $243K | Buy |
+3,653
| New | +$243K | 0.05% | 216 |
|